MedPath

汕头金石粉针剂有限公司

Ownership
-
Established
1994-04-29
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

66

NMPA:66

Drug Approvals

Ceftazidime and Avibactam Sodium for Injection

Product Name
注射用头孢他啶阿维巴坦钠
Approval Number
国药准字H20243954
Approval Date
Jun 4, 2024
NMPA

Cefpirome Sulfate for Injection

Product Name
注射用硫酸头孢匹罗
Approval Number
国药准字H20059130
Approval Date
Aug 24, 2020
NMPA

Cefpirome Sulfate for Injection

Product Name
注射用硫酸头孢匹罗
Approval Number
国药准字H20059129
Approval Date
Aug 24, 2020
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection(2:1)

Product Name
注射用头孢哌酮钠舒巴坦钠(2:1)
Approval Number
国药准字H20065098
Approval Date
May 27, 2020
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection(2:1)

Product Name
注射用头孢哌酮钠舒巴坦钠(2:1)
Approval Number
国药准字H20065099
Approval Date
May 27, 2020
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection(2:1)

Product Name
注射用头孢哌酮钠舒巴坦钠(2:1)
Approval Number
国药准字H20065097
Approval Date
May 26, 2020
NMPA

Cefoperazone Sodium and Sulbactam Sodium for Injection(2:1)

Product Name
注射用头孢哌酮钠舒巴坦钠(2:1)
Approval Number
国药准字H20065164
Approval Date
May 26, 2020
NMPA

Cefonicid Sodium for Injection

Product Name
注射用头孢尼西钠
Approval Number
国药准字H20058711
Approval Date
May 7, 2020
NMPA

Cefonicid Sodium for Injection

Product Name
注射用头孢尼西钠
Approval Number
国药准字H20058710
Approval Date
Apr 27, 2020
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20063453
Approval Date
Apr 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.